Mylan NV (NASDAQ:MYL)

40.78
Delayed Data
As of Apr 23
 +0.06 / +0.15%
Today’s Change
29.39
Today|||52-Week Range
47.82
-3.62%
Year-to-Date

Today’s Trading

Previous close40.72
Today’s open40.79
Day’s range40.50 - 40.99
Volume2,930,545
Average volume (3 months)5,320,108
Market cap$21.9B
Data as of 4:00pm ET, 04/23/2018

Growth & Valuation

Earnings growth (last year)+41.30%
Earnings growth (this year)+18.28%
Earnings growth (next 5 years)+6.30%
Revenue growth (last year)+7.06%
P/E ratio31.4
Price/Sales1.91
Price/Book1.67

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...-0.22-0.27%
PRGOPerrigo Company PLC+0.37+0.45%
JAZZJazz Pharmaceuticals...-2.31-1.46%
ALNYAlnylam Pharmaceutic...-1.62-1.66%
Data as of 4:02pm ET, 04/23/2018

Financials

Next reporting dateMay 3, 2018
EPS forecast (this quarter)$1.10
Annual revenue (last year)$11.9B
Annual profit (last year)$696.0M
Net profit margin5.85%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Heather M. Bresch
President &
Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts